Navigation Links
Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
Date:8/5/2008

aterially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors and risks that may affect the forward-looking statements include the results of this and future clinical studies, the ability to obtain regulatory approvals for MTRX1011A, the introduction and impact of competing therapies by other companies and the dependence of Tolerx upon Genentech for further development of MTRX1011A. These statements reflect the view of Tolerx as of the date of this press release, and Tolerx undertakes no obligation to update or revise any forward- looking statements to reflect events or circumstances after the date of this press release.


'/>"/>
SOURCE Tolerx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
2. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
3. Medarex Announces Allowance of Investigational New Drug Application for Wholly-Owned Fully Human Anti-PD-L1 Antibody, MDX-1105
4. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
5. MicroDose Technologies Announces Achievement of Phase I Clinical Milestone Triggering First Milestone Payment Under Collaboration with Merck & Co., Inc.
6. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Anpath Group, Inc. Announces Approval of its Disinfectant by the State of Florida
9. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
11. Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BioPharmX Corporation (NYSE MKT: BPMX) a Silicon Valley-based ... chief executive officer and co-founder of BioPharmX, will present at ... place, September 8-10, 2015 at The St. Regis Hotel, ... scheduled to present on September 10 from 2:10 to 2:35 ... A live webcast of the presentation will be ...
(Date:9/2/2015)... 2, 2015 Tumultuous market conditions – including ... care M&A activity – have led more than half ... pharmaceutical sales reps. This marks the first time that ... the halfway point, according to the spring 2015 ... ZS . AccessMonitor™ aggregates ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics (Kastle), ... commercializing pharmaceuticals for diseases with high unmet medical ... executives to key commercial operating positions. ... President, Commercial; Sean was previously Global Marketing Director ... appointed as Director, Commercial Strategy and Analytics; Nick ...
Breaking Medicine Technology:Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
... 7, 2011 Akorn, Inc. (NASDAQ: AKRX ... 2011, to discuss third quarter 2011 results followed by a ... day before the market opens. Subject: , Akorn, Inc. ... 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , (888) ...
... PARSIPPANY, N.J., Oct. 7, 2011 Watson Pharmaceuticals, Inc. ... subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated ... Drug Administration (FDA) seeking approval to market Morphine Sulfate ... mg/2 mg, 60 mg/2.4 mg, 80 mg/3.2 mg, and ...
Cached Medicine Technology:Watson Confirms EMBEDA(R) Patent Challenge 2Watson Confirms EMBEDA(R) Patent Challenge 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... reputation for the telling the truth about medicine and health, truths that other ... video blog, where he plans to regularly debunk certain misconceptions surrounding cholesterol, metabolically ...
(Date:9/1/2015)... , ... September 01, 2015 , ... For many men, the first thing they notice ... were often forced to wear a looser fitting shirt with a collar that doesn’t close ... a finger between their collar and skin all day because it’s uncomfortable. Now men ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Economics, the author explained how many dental practices across the country are switching ... Manufacturing) technology. According to Beverly Hills cosmetic dentist Dr. Sam Saleh of Ora ...
(Date:9/1/2015)... ... 2015 , ... The Journal of Pain Research has published the ... , As corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic ... to better understand how migraine headaches impact the lives of migraineurs. We asked migraineurs ...
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... According ... Medical Association, individuals with type 2 diabetes that participated in a three year study ... three years down the line if they elected weight loss surgery at the onset ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Rothman, NJ’s Leading Holistic Doctor, Presents a Video Blog that Discusses the Most Confusing and Interesting Current Medical Topics 2Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2Health News:Article on CAD/CAM Dental Technology Highlights the Advantages of 21st Century Dentistry, Notes Ora Dentistry Spa 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Recent Journal Article on Diabetes Remission Adds to the Growing Pile Of Evidence in Favor of Bariatric Surgery, Says Dr. Feiz and Associates 2
... 19 Delta Dental of Illinois has ... of Illinois at Chicago,College of Dentistry to ... renovations are complete, the clinic will be ... Dentistry Clinic., (Photo: http://www.newscom.com/cgi-bin/prnh/20071219/AQW128 ), ...
... Ind., Dec. 19 Zimmer Holdings, Inc.,(NYSE: ZMH ... announced,today it will be participating in the 26th Annual ... at 12:00 p.m. Eastern Time., A live webcast ... website at http://investor.zimmer.com . The webcast will,be archived ...
... takes the first step in offering nationwide services, ... announced its plan to expand its services to four ... Area during,the summer of 2007, and is now expanding ... The company hosts a website where healthcare,providers and patients ...
... (MGH) researchers have identified a new molecular pathway that ... This early-stage kidney disease affects 100 million people around ... the kidneys filtering structures. Blocking this pathway could ... slow the process of kidney failure. The research ...
... Device might aid in the detection and monitoring of cancer, ... U.S. team has developed a microchip device that can detect ... has a silicon chip with about 80,000 microscopic posts. Each ... expressed by most solid tumors. The device is able to ...
... Massachusetts General Hospital (MGH) Biomicroelectromechanical Systems (BioMEMS) Resource Center ... device that can isolate, enumerate and analyze circulating tumor ... viable cells from solid tumors carried in the bloodstream ... Because of their rarity and fragility, it has ...
Cached Medicine News:Health News:Delta Dental of Illinois Announces Major Gift to University of Illinois at Chicago College of Dentistry 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 2Health News:Receptor protein appears to be key in breakdown of kidney filtration 3Health News:Microchip Spots Stray Tumor Cells in the Bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 2Health News:Microchip-based device can detect rare tumor cells in bloodstream 3
... Osteopal V is a low viscosity bone ... in vertebroplasty. The bone cement is injected ... purposes. Osteopal V is used for the ... of zirconium dioxide is included in the ...
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... a comprehensive platform for standard neurosurgical ... to plan the optimal surgical path ... Combined with unique features such as ... planning tool, Neurosight becomes a very ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with our displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless...
Medicine Products: